Explore 3 Stock Ideas & Industry Insights Download Free Report

News

A Widening Loss and Heavy Debt Overshadow Advantage Solutions' (NASDAQ:ADV) Mixed Quarter

Advantage Solutions (NASDAQ:ADV) helps consumer-goods brands and retailers sell their products through in-store demos, merchandising and sales support. A widening loss and heavyDebtweigh on the shares this quarter, even as the company's experientialBusinesscontinues to grow strongly, a divergence that makes the underlying mix of …

Nitish Kishor | 21 September 2026

S&P SmallCap 600 Stock ADMA Biologics (NASDAQ:ADMA) Rides One Plasma Product to Growth

ADMA Biologics (NASDAQ:ADMA) makes medicines from human plasma, and a specialty immune-boosting product for vulnerable patients has become the company's dominant growth engine. Rising sales of that high-margin product lifted profits again in the second quarter, even as an older, lower-margin product in the …

Nitish Kishor | 21 September 2026

Adient (NYSE:ADNT) Absorbs Temporary Headwinds, Holds Its Full-Year Outlook

Adient (NYSE:ADNT) makes the seats in millions of cars worldwide, so its fortunes track global vehicle production and its own cost discipline on notoriously thin margins. The company's third fiscal quarter tells a story that is easy to summarize but worth reading carefully: results …

Nitish Kishor | 21 September 2026

S&P 500 Stock Automatic Data Processing (NASDAQ:ADP) Closes Fiscal 2026 With Double-Digit Profit Growth

Automatic Data Processing (NASDAQ:ADP) handlesPayrolland human-resources tasks for hundreds of thousands of employers, earning steady, recurring fees for a service businesses cannot easily do without. A solid close to fiscal 2026, double-digit profit growth alongside a healthy revenue increase, shows a mature, dividend-compoundingBusinessstill finding …

Nitish Kishor | 21 September 2026

Adaptive Biotechnologies (NASDAQ:ADPT): This Nasdaq Diagnostics Stock Plans a Split as Its MRD Testing Business Takes Off

Adaptive Biotechnologies (NASDAQ:ADPT) runs clonoSEQ, a test that detects tiny amounts of residual cancer in blood cancers, a diagnostic capability known as minimal or measurable residual disease testing. Fast-growing test volumes lifted revenue and profitability again this quarter, and the company plans to separate …

Nitish Kishor | 21 September 2026

Adagio Medical (NASDAQ:ADGM): This Nasdaq Medtech Stock Pairs Strong Trial Data With a Thin Cash Balance

Adagio Medical (NASDAQ:ADGM) is developing catheters that destroy the faulty heart tissue behind dangerous rhythm disorders, and its clinical results in a hard-to-treat condition are genuinely encouraging. But strong trial data alone doesn't pay the bills, and the company's own accounts point to a …

Nitish Kishor | 21 September 2026

S&P 500 Stock Analog Devices (NASDAQ:ADI) Posts a Record Quarter on AI and Industrial Demand

Analog Devices (NASDAQ:ADI) makes the chips that let machines sense and manage the real world, converting physical signals like temperature, pressure and motion into the digital data that electronics run on. That unglamorous but essential role just delivered a milestone: a record fiscal third …

Nitish Kishor | 21 September 2026

ADI Global Distribution (NYSE:ADIG) Tests Its Scale After Splitting From Resideo

ADI Global Distribution (NYSE:ADIG) supplies the security cameras, alarms, audio-visual gear and fire-safety equipment that installers fit in homes and businesses. Newly independent after splitting from Resideo Technologies, the company is now being judged on a single question: whether being a large, efficient middleman …

Nitish Kishor | 21 September 2026

A Shorter FDA Path Can't Solve Adial Pharmaceuticals' (NASDAQ:ADIL) Cash Problem

Adial Pharmaceuticals (NASDAQ:ADIL) is developing AD04, a pill intended to help genetically defined heavy drinkers cut down on alcohol consumption, and the company has recently pointed to a potentially shorter path to FDA approval as encouraging news. That regulatory possibility is real. But a …

Nitish Kishor | 21 September 2026

S&P 500 Stock Archer-Daniels-Midland (NYSE:ADM) Raises Its Outlook on Crush Margins and Nutrition

Archer-Daniels-Midland (NYSE:ADM) processes the world's crops into food, feed, fuel and ingredients, buying, storing, transporting and processing agricultural commodities at global scale. A strong second quarter, powered specifically by oilseed crushing margins and a recovering nutrition arm, let the company raise its full-year guidance …

Nitish Kishor | 21 September 2026
Support

Hi! How can we help you today?

Loading…